Top Cited Articles
Acceptance rate:
31%
Time to first decision:
7 days
Time to first decision with review:
52 days*
Acceptance to publication:
26 days*
Impact factor:
3.6
Citescore:
5.9
Impacts of COVID-19 on sexual behaviour in Britain: findings from a large, quasi-representative survey (Natsal-COVID)
Chemsex and incidence of sexually transmitted infections among Canadian pre-exposure prophylaxis (PrEP) users in the l'Actuel PrEP Cohort (2013-2020)
BASHH updated position statement on doxycycline as prophylaxis for sexually transmitted infections
Characteristics associated with Lactobacillus iners-dominated vaginal microbiota
Recent changes in the reporting of STIs in Japan during the COVID-19 pandemic
Accessing needed sexual health services during the COVID-19 pandemic in British Columbia, Canada: a survey of sexual health service clients
Sexual transmission of infections across Europe: appraising the present, scoping the future
Dose selection for a phase III study evaluating gepotidacin (GSK2140944) in the treatment of uncomplicated urogenital gonorrhoea
Adverse pregnancy and perinatal outcomes associated with Mycoplasma genitalium: systematic review and meta-analysis
Impact of COVID-19 pandemic on STIs in Greece
Evidence of HIV pre-exposure or post-exposure prophylaxis (PrEP/PEP) among blood donors: a pilot study, England June 2018 to July 2019
Clinical efficacy and tolerability of 1.5 g/day oral amoxicillin therapy without probenecid for the treatment of syphilis
'Stay at home...': exploring the impact of the COVID-19 public health response on sexual behaviour and health service use among men who have sex with men: findings from a large online survey in the UK
Is there an association between previous infection with <i>Neisseria gonorrhoeae</i> and gonococcal AMR? A cross-sectional analysis of national and sentinel surveillance data in England, 2015-2019
Changes in STI and HIV testing and testing need among men who have sex with men during the UK's COVID-19 pandemic response
STIs during the first and second wave of COVID-19 in Denmark
Impact of the early 2020 COVID-19 crisis and lockdown on PrEP use among men who have sex with men (MSM) in France
Chemsex, sexual behaviour and STI-PrEP use among HIV-PrEP users during the COVID-19 pandemic in Brighton, UK
Universal lymphogranuloma venereum (LGV) testing of rectal chlamydia in men who have sex with men and detection of asymptomatic LGV
Timing of primary syphilis treatment and impact on the development of treponemal antibodies: a cross-sectional clinic-based study